Skip to main content

CareScope Perch/Pharmacy & Prescribing

Not reviewed

This is a directory listing. We track it, but it has not been through a CareScope review, so there is no score and no assessment of it yet. Nothing here should be read as a recommendation.

Mark Cuban Cost Plus Drug Company

by Mark Cuban Cost Plus Drug Company

What we know so far

Category: Pharmacy & Prescribing

Segment: Not publicly available

Typical market: Not publicly available

PHI exposure: Not reviewed

Where this stands

We publish what we can verify and nothing more. A full review covers security, usability, integrations, reliability, support, AI readiness, value, and small-practice fit — the same eight criteria we use for every product. Until this one has been through that process, you will see no score, no strengths, and no cautions here.